Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Fontecha-Barriuso, Miguel
92  Ergebnisse:
Personensuche X
?
1

#1995 Runt-related Transcription Factor 1 (RUNX1) is a medi..:

Gómez, Natalia Villar ; Fontecha-Barriuso, Miguel ; Mauvecín, Juan Guerrero..
Nephrology Dialysis Transplantation.  39 (2024)  Supplement_1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
2

RIPK3 and kidney disease:

Guerrero-Mauvecin, Juan ; Fontecha-Barriuso, Miguel ; López-Diaz, Ana M...
Nefrología (English Edition).  44 (2024)  1 - p. 10-22 , 2024
Link: https://doi.org/10.1016/..
 
?
3

RIPK3 and kidney disease:

Guerrero-Mauvecin, Juan ; Fontecha-Barriuso, Miguel ; López-Diaz, Ana M...
Nefrología.  44 (2024)  1 - p. 10-22 , 2024
Link: https://doi.org/10.1016/..
 
?
4

The Urinary Level of Injury Biomarkers Is Not Univocally Re..:

Sancho-Martínez, Sandra M. ; Herrero, María ; Fontecha-Barriuso, Miguel..
International Journal of Molecular Sciences.  23 (2022)  7 - p. 3494 , 2022
Link: https://doi.org/10.3390/..
 
?
5

Tubular Mitochondrial Dysfunction, Oxidative Stress, and Pr..:

Fontecha-Barriuso, Miguel ; Lopez-Diaz, Ana M. ; Guerrero-Mauvecin, Juan...
Antioxidants.  11 (2022)  7 - p. 1356 , 2022
Link: https://doi.org/10.3390/..
 
?
6

Urinary Cyclophilin A as Marker of Tubular Cell Death and K..:

Cabello, Ramio ; Fontecha-Barriuso, Miguel ; Martin-Sanchez, Diego...
Biomedicines.  9 (2021)  2 - p. 217 , 2021
Link: https://doi.org/10.3390/..
 
?
7

Nicotinamide and acute kidney injury:

Fontecha-Barriuso, Miguel ; Lopez-Diaz, Ana M ; Carriazo, Sol..
Clinical Kidney Journal.  14 (2021)  12 - p. 2453-2462 , 2021
Link: https://doi.org/10.1093/..
 
?
8

The Role of PGC-1α and Mitochondrial Biogenesis in Kidney D..:

Fontecha-Barriuso, Miguel ; Martin-Sanchez, Diego ; Martinez-Moreno, Julio...
Biomolecules.  10 (2020)  2 - p. 347 , 2020
Link: https://doi.org/10.3390/..
 
?
9

Ferroptosis and kidney disease:

Martin-Sanchez, Diego ; Fontecha-Barriuso, Miguel ; Martinez-Moreno, Julio M....
Nefrología.  40 (2020)  4 - p. 384-394 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Molecular pathways driving omeprazole nephrotoxicity:

Fontecha-Barriuso, Miguel ; Martín-Sanchez, Diego ; Martinez-Moreno, Julio M....
Redox Biology.  32 (2020)  - p. 101464 , 2020
Link: https://doi.org/10.1016/..
 
?
11

The Contribution of Histone Crotonylation to Tissue Health ..:

Martinez-Moreno, Julio M. ; Fontecha-Barriuso, Miguel ; Martín-Sánchez, Diego...
Frontiers in Pharmacology.  11 (2020)  - p. , 2020
Link: https://doi.org/10.3389/..
 
?
12

Epigenetic Modifiers as Potential Therapeutic Targets in Di..:

Martinez-Moreno, Julio M. ; Fontecha-Barriuso, Miguel ; Martin-Sanchez, Diego...
International Journal of Molecular Sciences.  21 (2020)  11 - p. 4113 , 2020
Link: https://doi.org/10.3390/..
 
?
13

Ferroptosis and kidney disease:

Martin-Sanchez, Diego ; Fontecha-Barriuso, Miguel ; Martinez-Moreno, Julio M....
Nefrología (English Edition).  40 (2020)  4 - p. 384-394 , 2020
Link: https://doi.org/10.1016/..
 
?
14

Urinary TCP1-eta: A Cortical Damage Marker for the Pathophy..:

López-Hernández, Francisco J ; López-Novoa, José M ; Arias, Manuel...
Toxicological Sciences.  174 (2019)  1 - p. 3-15 , 2019
Link: https://doi.org/10.1093/..
 
?
15

Targeting of regulated necrosis in kidney disease:

Martin-Sanchez, Diego ; Poveda, Jonay ; Fontecha-Barriuso, Miguel...
Nefrología (English Edition).  38 (2018)  2 - p. 125-135 , 2018
Link: https://doi.org/10.1016/..
 
1-15